ATT: DOCTORS - ZOOM PRESENTATION: March 9, 2021 7:00 PM EST- NEW FDA CLEARED Closed Loop Point-of-Care MicroFat Tissue Processing

ATT: DOCTORS - ZOOM PRESENTATION: March 9, 2021 7:00 PM EST- NEW FDA CLEARED Closed Loop Point-of-Care MicroFat Tissue Processing

Jointech Labs Presentation and Discussion- March 9, 2021 - NEW FDA CLEARED DEVICE for Point-of-Care Fat Tissue Processing for a Broad Range of Applications

You are invited to the next ZOOM Presentation on Tuesday March 9th at 7PM EST to introduce the launch of the new Jointech MiniTC closed loop tissue processing device for Cell Enriched Microfat. This Device is a quantum leap forward from other existing devices, and is a cost effective system that is user friendly.

MiniTCTM is FDA cleared sterile closed-loop disposable medical device for processing of lipoaspirate (fat). The final product of the processing is a fine washed fractured fat tissue known as micronized fat or nanofat. It’s intended for autologous multi-functional implant alone or in conjunction with other biocompatible carriers. The device can be used in a broad range of therapeutic areas, such as orthopedics, aesthetics, plastic corrective surgeries, and wound care (the company has received FDA clearance for a broad range of surgical applications). As a closed-loop device, MiniTC (MTC) allows for processing of lipoaspirate of adipose tissue without exposure to the external environment in virtually any type of clinical setting. When implanted by injection, the essential eff ect can be attributed to the preservation of the integrity of adipose tissue lobules and the stromal cells within its natural niche. Together it constitutes structural and trophic factors that trigger the reconstruction, regeneration and healing of connective tissues, which is well recognized in the field of musculoskeletal disorders. 

MiniTC is a disposable, closed loop medical device that can be used in the clinic setting, with no change in infrastructure, eliminating the need for manual processing of fat tissue in the lab. Also, the device is less costly, cumbersome and labor intensive compared to what currently exists. MiniTC’s performance has been validated in vitro and in vivo, including an observational orthopedic study in Israel and the UAE, involving 47 patients – with 92% reporting functional improvement and no complications. Additionally, it was validated in clinical studies with lymphoedema patients as well as in the areas of facial aesthetics, hair regrowth and wound care. There are other studies available for validation as well as analysis of the components in the finished product after processing.

“Jointechlabs’ MiniTC device is easy to use and effective,” said Joseph Purita, M.D., orthopedic surgeon and director of the Institute of Regenerative Medicine in Boca Raton, Florida. “It is encouraging to see the continuing development of new technology for regenerative medicine that is compliant with FDA guidelines."

Microfat Isolation

MiniTC allows for processing of of adipose (fat) tissue without exposure to the external environment. The final product of the processing is a fine washed fractured fat tissue known as fat graft or microfat. When implanted by injection, the essential effect can be attributed to the preservation of the integrity of fat tissue and the stromal cells within its natural niche. Together it constitutes structural factors that trigger the reconstruction, regeneration and healing of connective tissues. It’s a gentle process that uses an individual’s own fat tissue to cushion and support areas of injury or damage as the body heals itself.

This is a great opportunity for anyone interested in the latest in Human Biologics. Please do not hesitate to reach out to me with any questions, comments or feedback, I am more than Happy to provide more information to interested potential users.

This Webinar will be handled as a ZOOM call and here is how you can participate:

When: Wednesday, Tuesday March 9th, 2021 7:00 PM EST

Jointechlabs is inviting you to a scheduled Zoom meeting.

Topic: Jointech: MiniTC as an universal platform for adipose-based regenerative therapies 

Time: Mar 9, 2021 06:00 PM Central Time (US and Canada)

Join Zoom Meeting

https://us02web.zoom.us/j/83225411876?pwd=Y0VqamU0d3VXRjdkRXhrOWtBRkVmZz09

Meeting ID: 832 2541 1876

Passcode: 013344

For more information please inbox me or email me at:

[email protected]

Thank you and i look forward to your participation

Gabriel Ellena

Médico cirujano en Centro médico flebologia estética y medicina regenerativa

1 年

Muchas gracias estamos en contacto

回复
Dr Jeannie Devereaux (PhD)

PhD Medical and Biological Sciences, BHlthSc (Dermal), BSc (1st Hons)

3 年

Is there a recording of this webinar. I missed it.

回复
Jonathan Schwartz

CEO at MEDICALMARVELS LLC

4 年

Thank you to all who participated in this ZOOM WEBINAR. I will be hosting another one in a couple of weeks- stay tuned. Anyone else who is interested in the interim can inbox me for more information on this opportunity.

回复

要查看或添加评论,请登录

社区洞察

其他会员也浏览了